entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 15:15:34 - browse：6

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Traditional Chinese medicine benefits explored in new JAMA study

knowledge

hotspot

WSS

How digital therapeutics firms are pivoting after Pear's bankruptcy

Testing for cancer recurrence creates a new limbo for patients

Prior authorization will have to move faster under new Biden rule

NIH director takes cautious approach to Biden drug pricing priority

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Biden's order seeks to regulate AI risk without stifling innovation

knowledge

entertainment

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Senate panel to vote on hospitals, PBMs, prisoner care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How digital therapeutics firms are pivoting after Pear's bankruptcy

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Eli Lilly, Pfizer, and others want in on the online prescription market

Continuity nursing helped my family in our darkest PICU moments

CDC recommends rationing of RSV shot due to shortages

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

leisure time

The surgeon had a dilemma only a Nazi medical text could resolve

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Maker of FluMist seeks to allow at

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Telehealth options flood the market as retailers push virtual care

knowledge

hotspot

knowledge

focus